Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction
The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Genetic variation may partially underlie complex personality and physiological traits--such as impulsivity, risk taking and stress responsivity--as well as a substantial proportion of vulnerability to addictive diseases. Furthermore, personality and physiological traits themselves may differentially affect the various stages of addiction, defined chronologically as initiation of drug use, regular drug use, addiction/dependence and potentially relapse. Here we focus on recent approaches to the study of genetic variation in these personality and physiological traits, and their influence on and interaction with addictive diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Common genetic liability to early, risky behaviors is characteristic of both AD39 and age of first birth40.”
From Transancestral GWAS of alcohol dependence reveals common genetic underpinnings with psychiatric disorders (2018) · cites this paper as [39]
In the citing paper
“Polymorphisms in several genes in the dopaminergic system, which targets the frontal and limbic brain structures that regulate impulsive behavior, have been identified as likely contributors to impulsivity (Kreek et al., 2005).”
From Impulsivity, frontal lobes and risk for addiction (2009) · cites this paper as Kreek et al., 2005
In the citing paper
“Such genetically variation in COMT function may also contribute to other forms of impulsive behavior (Congdon and Canli, 2005; Cools and Robbins, 2004; Kreek et al., 2005).”
From Impulsivity, frontal lobes and risk for addiction (2009) · cites this paper as Kreek et al., 2005
In the citing paper
“Prolonged exposure to stress can lead to irregular changes in GC receptor density (epigenetics) which may increase the reinforcing effects of alcohol and drugs [177,178].”
From Food Addiction and Psychosocial Adversity: Biological Embedding, Contextual Factors, and Public Health Implications (2020) · cites this paper as [178]
Citations
Cites
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene
Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite, A., et al. (2003) · Science · doi:10.1126/science.1083968 · Cited by 8,120
Role of genotype in the cycle of violence in maltreated children
Caspi, A., McClay, J., Moffitt, T. E., Mill, J., Martin, J., Craig, I. W., Taylor, A., & Poulton, R. (2002) · Science · doi:10.1126/science.1072290 · Cited by 4,842
Lachman, H. M., Papolos, D. F., Saito, T., Yu, Y.-M., Szumlanski, C. L., & Weinshilboum, R. M. (1996) · Pharmacogenetics · doi:10.1097/00008571-199606000-00007 · Cited by 1,788
Bond, C., LaForge, K. S., Tian, M., Melia, D., Zhang, S., Borg, L., Gong, J., Schluger, J., Strong, J. A., Leal, S. M., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9608 · Cited by 1,074
Self-citationTsuang, M. T., Lyons, M. J., Meyer, J. M., Doyle, T., Eisen, S. A., Goldberg, J., True, W., Lin, N., Toomey, R., & Eaves, L. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.11.967 · Cited by 710
Kendler, K. S., Jacobson, K. C., Prescott, C. A., & Neale, M. C. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.4.687 · Cited by 693
Edenberg, H. J., Dick, D. M., Xuei, X., Tian, H., Almasy, L., Bauer, L. O., Crowe, R. R., Goate, A., Hesselbrock, V., Jones, K., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/383283 · Cited by 655
Neville, M. J., Johnstone, E. C., & Walton, R. T. (2004) · Human Mutation · doi:10.1002/humu.20039 · Cited by 510
O'Malley, S., Krishnan-Sarin, S., Farren, C., Sinha, R., & Kreek, M. (2002) · Psychopharmacology · doi:10.1007/s002130100919 · Cited by 492
Self-citationHu, X., Oroszi, G., Chun, J., Smith, T. L., Goldman, D., & Schuckit, M. A. (2005) · Alcoholism: Clinical & Experimental Research · doi:10.1097/01.alc.0000150008.68473.62 · Cited by 484
Diagnosis and Symptoms of Depression in Opiate Addicts: Course and Relationship to Treatment Outcome
Rounsaville, B. J. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290020021004 · Cited by 410
Pharmacogenetics and Human Molecular Genetics of Opiate and Cocaine Addictions and Their Treatments
Kreek, M. J., Bart, G., Lilly, C., Laforge, K. S., & Nielsen, D. A. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.1.1 · Cited by 391
Self-citationKreek, M. J., LaForge, K. S., & Butelman, E. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd897 · Cited by 374
Self-citationNielsen, D. A. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950010034005 · Cited by 372
Self-citationSinha, R., Talih, M., Malison, R., Cooney, N., Anderson, G. M., & Kreek, M. J. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1525-8 · Cited by 366
Self-citationA missense mutation in human fatty acid amide hydrolase associated with problem drug use
Sipe, J. C., Chiang, K., Gerber, A. L., Beutler, E., & Cravatt, B. F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082235799 · Cited by 355
Wang, J. C. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh194 · Cited by 331
A Tryptophan Hydroxylase Gene Marker for Suicidality and Alcoholism
Nielsen, D. A., Virkkunen, M., Lappalainen, J., Eggert, M., Brown, G. L., Long, J. C., Goldman, D., & Linnoila, M. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.7.593 · Cited by 293
Self-citationZhang, P.-W., Ishiguro, H., Ohtsuki, T., Hess, J., Carillo, F., Walther, D., Onaivi, E. S., Arinami, T., & Uhl, G. R. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001560 · Cited by 247
Alcoholism Susceptibility Loci: Confirmation Studies in a Replicate Sample and Further Mapping
Foroud, T., Edenberg, H. J., Goate, A., Rice, J., Flury, L., Koller, D. L., Bierut, L. J., Conneally, P. M., Nurnberger, J. I., Bucholz, K. K., et al. (2000) · Alcoholism: Clinical and Experimental Research · doi:10.1097/00000374-200007000-00001 · Cited by 245
DRD4 and novelty seeking: Results of meta‐analyses
Schinka, J. A., Letsch, E. A., & Crawford, F. C. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10649 · Cited by 230
Bart, G., Kreek, M. J., Ott, J., LaForge, K. S., Proudnikov, D., Pollak, L., & Heilig, M. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300598 · Cited by 220
Self-citationKosten, T. A., Miserendino, M. J. D., Haile, C. N., DeCaprio, J. L., Jatlow, P. I., & Nestler, E. J. (1997) · Brain Research · doi:10.1016/s0006-8993(97)01205-5 · Cited by 181
Cubells, J. F., Kranzler, H. R., McCance-Katz, E., Anderson, G. M., Malison, R. T., Price, L. H., & Gelernter, J. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000657 · Cited by 179
Bart, G., Heilig, M., LaForge, K. S., Pollak, L., Leal, S. M., Ott, J., & Kreek, M. J. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001504 · Cited by 177
Self-citationCannabinoid receptor gene (CNR1): association with IV drug use
Comings, D. E., Muhleman, D., Gade, R., Johnson, P., Verde, R., Saucier, G., & MacMurray, J. (1997) · Molecular Psychiatry · doi:10.1038/sj.mp.4000247 · Cited by 175
Opioid receptor and peptide gene polymorphisms: potential implications for addictions
LaForge, K. S., Yuferov, V. P., & Kreek, M. J. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00819-0 · Cited by 167
Self-citationPrimus, R. J., Thurkauf, A., Xu, J., Yevich, E., Mcinerney, S., Shaw, K., Tallman, J. F., & Gallager, D. W. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36885-5 · Cited by 162
Genes Associated With Addiction: Alcoholism, Opiate, and Cocaine Addiction
Kreek, M. J., Nielsen, D. A., & LaForge, K. S. (2004) · NeuroMolecular Medicine · doi:10.1385/nmm:5:1:085 · Cited by 159
Self-citationAssociation of a CB1 Cannabinoid Receptor Gene (CNR1) polymorphism with severe alcohol dependence
Schmidt, L. G., Samochowiec, J., Finckh, U., Fiszer-Piosik, E., Horodnicki, J., Wendel, B., Rommelspacher, H., & Hoehe, M. R. (2002) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(01)00164-8 · Cited by 154
Substance abuse vulnerability and D2 receptor genes
Uhl, G. R., Blum, K., Noble, E. P., & Smith, S. S. (1993) · Trends in Neurosciences · doi:10.1016/0166-2236(93)90128-9 · Cited by 139
Zhou, Y., Spangler, R., LaForge, K. S., Maggos, C. E., Ho, A., & Kreek, M. J. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20974-0 · Cited by 137
Self-citationGelernter, J. E., Panhuysen, C. I. M., Weiss, R. D., Brady, K. T., HESSELBROCK, V. M., Rounsaville, B. J., Poling, J. C., Wilcox, M., Farrer, L. A., & Kranzler, H. R. (2005) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30189 · Cited by 134
Yuferov, V., Fussell, D., LaForge, K. S., Nielsen, D. A., Gordon, D., Ho, A., Leal, S. M., Ott, J., & Kreek, M. J. (2004) · Pharmacogenetics · doi:10.1097/00008571-200412000-00002 · Cited by 128
Self-citationOpiates, opioids and addiction.
Kreek, M. J. (1996) · PubMed · Cited by 126
Self-citationAssociation analysis of the DRD4 and COMT genes in methamphetamine abuse
Li, T., Chen, C. Y., Hu, X., Ball, D., Lin, S., Chen, W., Sham, P. C., Loh, E., Murray, R. M., & Collier, D. A. (2004) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30024 · Cited by 124
Lusher, J. M., Chandler, C., & Ball, D. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000918 · Cited by 119
Genetic and Environmental Influences on Transitions in Drug Use
Tsuang, M. T., Lyons, M. J., Harley, R. M., Xian, H., Eisen, S. A., Goldberg, J. H., True, W. R., & Faraone, S. V. (1999) · Behavior Genetics · doi:10.1023/a:1021635223370 · Cited by 112
Coccaro, E. F. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950040062008 · Cited by 109
LEVIN, F. R., & Kleber, H. D. (1995) · Harvard Review of Psychiatry · doi:10.3109/10673229509017144 · Cited by 108
Substance abuse vulnerability loci: converging genome scanning data
Uhl, G. R., Liu, Q., & Naiman, D. Q. (2002) · Trends in Genetics · doi:10.1016/s0168-9525(02)02719-1 · Cited by 98
Schluger, J. H., Borg, L., Ho, A., & Kreek, M. J. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00222-0 · Cited by 92
Horowitz, R., Kotler, M., Shufman, E., Aharoni, S., Kremer, I., Cohen, H., & Ebstein, R. P. (2000) · American Journal of Medical Genetics · doi:10.1002/1096-8628(20001009)96:5<599::aid-ajmg4>3.0.co;2-o · Cited by 92
Uhl, G. R. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1316.001 · Cited by 84
Oswald, L. M., McCaul, M. E., Choi, L., Yang, X., & Wand, G. S. (2003) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.07.003 · Cited by 53
Limosin, F., Romo, L., Batel, P., Adès, J., Boni, C., & Gorwood, P. A. P. M. (2005) · European Psychiatry · doi:10.1016/j.eurpsy.2005.02.004 · Cited by 46
Ott, J. (2004) · Human Heredity · doi:10.1159/000083544 · Cited by 17
The A1 Allele at the D2 Dopamine Receptor Gene and Alcoholism: A Reappraisal
Gelernter, J. (1993) · JAMA · doi:10.1001/jama.1993.03500130087038 · Cited by 2
(1997) · doi:10.1002/(sici)1096-8628(19970725)74:4
Research works printed but not linked: 2
- Kreek, M.J. Medical safety, side effects and toxicity of methadone. Proceedings of the Fourth National Conference on Methadone Treatment, National Association for the Prevention of Addiction to Narcotics (NAPAN)-NIMH, 171–174 (1972).
- Vandenbergh, D.J., Rodriguez, L.A., Miller, I.T., Uhl, G.R. & Lachman, H.M. High-activity catechol-O-methyltransferase allele is more prevalent in polysubstance abusers. Am. J. Med. Genet. 74, 439–442 (1997). · doi:10.1002/(sici)1096-8628(19970725)74:4<439::aid-ajmg16>3.0.co;2-j
Cited by
Chronic stress, drug use, and vulnerability to addiction
Sinha, R. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1441.030 · Cited by 1,904
Impulsivity, compulsivity, and top-down cognitive control
Dalley, J. W., Everitt, B. J., & Robbins, T. W. (2011) · Neuron · doi:10.1016/j.neuron.2011.01.020 · Cited by 1,589
Verdejo-García, A., Lawrence, A. J., & Clark, L. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2007.11.003 · Cited by 1,422
High Impulsivity Predicts the Switch to Compulsive Cocaine-Taking
Belin, D., Mar, A. C., Dalley, J. W., Robbins, T. W., & Everitt, B. J. (2008) · Science · doi:10.1126/science.1158136 · Cited by 989
Neurobiology of Aggression and Violence
Siever, L. J. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07111774 · Cited by 984
“A number of other genes in the serotonergic and catecholaminergic systems have been associated with impulse control deficits (129).”
Background
Metadata
- Authors
- Kreek, M. J., Nielsen, D. A., Butelman, E. R., & LaForge, K. S.
- Affiliations
- Rockefeller University (US)
- Venue
- Nature Neuroscience
- Published
- 2005-10-26
- Volume
- 8
- Issue
- 11
- Pages
- 1450-1457
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W2165387836
- Cited by
- 1,024
- References
- 49
- Citations by year
- 2026: 10 · 2025: 16 · 2024: 22 · 2023: 24 · 2022: 46 · 2021: 39 · 2020: 64 · 2019: 51 · 2018: 57 · 2017: 56 · 2016: 61 · 2015: 68 · 2014: 65 · 2013: 64 · 2012: 80
- FWCI
- 3.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (2m01rr000102-41)
- National Institute on Drug Abuse (K05 DA00049, K05DA000049, P60 DA 05130, P60DA005130)
- National Center for Research Resources (M0-1 RR00102)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- impulsivity, risk-taking, stress responsivity, drug abuse vulnerability, addiction, genetic variation, personality traits, physiological traits, gene-environment interaction, relapse, drug addiction
- MeSH terms
- Animals, Humans, Impulsive Behavior, Models, Biological, Personality, Risk-Taking, Stress, Physiological, Genetic Variation, Comorbidity, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.